Intraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride
- 11 January 2011
- journal article
- clinical trial
- Published by Wiley in Acta Ophthalmologica
- Vol. 89 (1) , e57-e63
Abstract
This prospective, multicenter, single-masked study evaluated the additive effect of dorzolamide hydrochloride 2% on the diurnal intraocular pressure (IOP) curve and retinal and retrobulbar hemodynamics in patients with primary open-angle glaucoma (POAG) treated with morning-dosed bimatoprost 0.03%. Eighty-nine patients (aged, 60.7 ± 11.8 years, range 33-80; 68 women) with POAG received bimatoprost dosed once in the morning for 1 month, after which dorzolamide was added twice daily for 2 months. IOP (Goldmann) and arterial blood pressure (BP) and diurnal ocular perfusion pressures (OPP) were measured every 2 hr for 24 hr. Heidelberg retina flowmetry of the retinal microcirculation was recorded four times daily in 64 patients and colour Doppler imaging of the ophthalmic and central retinal arteries was recorded five times daily in 25 patients. All measurements were taken after the two phases of treatment and compared using anova analysis with Bonferroni adjustment. Mean baseline IOP was 16.5 ± 3.4 mmHg. Mean diurnal IOP with dorzolamide adjunctive therapy (12.9 ± 2.1 mmHg) was significantly lower compared to mean IOP with bimatoprost monotherapy (13.6 ± 2.2 mmHg) (p = 0.03). Adjunctive dorzolamide therapy significantly decreased vascular resistance in the ophthalmic artery (p = 0.02). Mean diastolic BP and OPP were significantly lower after adjunctive therapy. There were no changes in retinal microcirculation between the two phases of treatment. Adjunctive dorzolamide therapy to morning-dosed bimatoprost 0.03% reduced diurnal IOP and vascular resistance in the ophthalmic artery but did not alter retinal circulation in this group of patients with POAG.Keywords
This publication has 41 references indexed in Scilit:
- Effects of the Timolol-Dorzolamide Fixed Combination and Latanoprost on Circadian Diastolic Ocular Perfusion Pressure in GlaucomaInvestigative Ophthalmology & Visual Science, 2008
- 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucomaCurrent Medical Research and Opinion, 2008
- Variable Involvement of the Perivascular Retinal Tissue in Carbonic Anhydrase Inhibitor–Induced Relaxation of Porcine Retinal Arterioles In VitroInvestigative Ophthalmology & Visual Science, 2007
- Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre studyBritish Journal of Ophthalmology, 2006
- Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertensionBritish Journal of Ophthalmology, 2006
- Additive Effect of Dorzolamide or Carteolol to Latanoprost in Primary Open-angle GlaucomaJournal of Glaucoma, 2006
- Glaucoma progression is associated with decreased blood flow velocities in the short posterior ciliary arteryBritish Journal of Ophthalmology, 2006
- 24-Hour Intraocular Pressure Control Obtained with Evening- versus Morning-Dosed Travoprost in Primary Open-Angle GlaucomaOphthalmology, 2006
- Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medicationCurrent Medical Research and Opinion, 2005
- Effect of dorzolamide and timolol on ocular blood flow in patients with primary open angle glaucoma and ocular hypertensionBritish Journal of Ophthalmology, 2005